10x Genomics, Inc. provided revenue guidance for full year 2022. For the period, the company expects revenue guidance of $500 million to $520 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.87 USD | -2.93% | -2.45% | -60.92% |
03/06 | Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target | MT |
29/05 | 10x Genomics, Inc. Launches 5,000-Plex Gene Panel for Xenium | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.92% | 2.62B | |
-7.41% | 11.98B | |
-5.68% | 8B | |
+7.41% | 5.85B | |
+28.87% | 5.54B | |
-15.84% | 3.84B | |
+10.70% | 2.66B | |
-7.96% | 2.33B | |
-8.85% | 1.78B | |
-6.39% | 1.45B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for Full Year 2022